drug pair in the treatment of non-alcoholic fatty liver disease Huafeng Chen, Shengzhe Yan, Qianru Xiang, Jiamin Liang, Xuejian Deng, Wanqin He, Yanzhen Cheng, Li Yang BMC Complementary Medicine and Therapies.2024;[Epub] CrossRef Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism Xu Dong, Yu-Ting Xiong, Tingting He, Congyang Zheng, Junjie Li, Yingjie Zhuang, Yingjie Xu, Ye Xiu, Zhixin Wu, Xiaomei Zhao, Xiaohe Xiao, Zhaofang Bai, Lili Gao Genes & Nutrition.2024;[Epub] CrossRef Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-B pathway Junyi Chen, Shuzhan Yang, Hanxia Luo, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Feiyue Chen, Danning Xu, Nan Cao International Immunopharmacology.2024

Genetic predisposition, sedentary lifestyle, dietary factors, and gut-derived elements contribute to obesity, insulin resistance, and adipose tissue dysfunction
Patients using prescribed cannabis should ensure all clinicians are aware of their full medication list
And that is just the resting metabolic rate change, before factoring in the other hormonal disruptions happening simultaneously
Step 5: Clarify Logistics and Administration Explain the practical aspects of therapy, including timing, routine integration, and access